WELCOME to epgonline.org

Welcome to epgonline.org, a free online source of credible and independent scientific content intended for healthcare professionals in the United Kingdom that brings all the medical information you need into one place, providing education and guidance to help with the diagnosis and treatment of your patients.

This website provides:

  • Drug information, categorised using the ATC Classification System, providing indication, dosage, administration and precautions.
  • Specialty and disease information, categorising specialties and diseases using the ICD-10 classification, with further insight found in the Disease Focus area.
  • The Horizons series of articles, written by our team of specialists, that ask what the future of healthcare holds, evaluating emerging trends to provide expert insight.
  • The latest news to keep you up-to-date with current advancements in drug development, advocacy and awareness, industry mergers and acquisitions, clinical trial progression and congress information.
  • Recent opinion articles shared with us by healthcare professionals to express their views and experiences.
  • A wide variety of accredited internal and external CME modules and courses, designed to educate on the latest care strategies for specific conditions.
  • The latest studies, trials and guidelines from global publications provide a comprehensive collection of current and past developments in medicine, helping you to provide best practice.
  • Medical applications that deliver creative solutions to aid in the diagnosis and treatment of your patients.
  • Specialist educational microsites, or Learning Zones, each devoted to self-directed medical education surrounding a specific disease, condition or procedure.

Registration is quick and simple, giving you unlimited access to all content and features, allowing you to save pages, comment on your favourite articles and access the personalised dashboard.

Latest News

Added 2 hours ago Drug news

Anixa Biosciences has filed an IVD pre-submission with the FDA for use of its Cchek artificial intelligence based cancer detection technology, as a prostate cancer test.

Anixa Biosciences formerly ITUS Corporation , a biotechnology company focusing on cancer diagnostics for all cancers and CAR-T cell immunotherapy...

Added 2 hours ago Drug news

Phase III SAkuraSky Study shows SA 237 cuts risk of relapse in neuromyelitis optica.- Chugai Pharma.

Chugai Pharmaceutical announced new results from the phase III study of SA 237 (satralizumab) SAkuraSky Study (NCT02028884) for the treatment...

Added 2 hours ago Drug news

FDA approves Yutiq for chronic non-infectious uveitis.- EyePoint Pharma.

EyePoint Pharmaceuticals announced that the FDA has approved Yutiq (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious uveitis...

Selected congress insight

The Asthma Report

ERS 2018 | Day 1 Highlights

Posted 29 days ago

News and insight from our reporting team at ERS 2018, who looked at one of the sessions covering novel pharmacological therapies in airway disease. 

The Asthma Report

ERS 2018 | Day 2 Highlights

Posted 1 month ago

A summary of the sessions from the State of the art airways programme at the European Respiratory Society Congress 2018.

Antithrombosis News

ESC 2018: Antithrombosis News congress highlights

Posted 1 month ago

Follow us on Facebook or Twitter now to get more ESC 2018 highlights and congress reports.

Antithrombosis News

ESC 2018 Day 1 highlights: National prescribing and adverse event rates of patients at risk of stroke with non-valvular AF.

Posted 1 month ago

Stroke prevention for patients with non-valvular atrial fibrillation is a key topic at ESC 2018. Follow us on Facebook or Twitter now to get more ESC 2018 highlights and congress reports.